C

Cannara Biotech Inc
XTSX:LOVE

Watchlist Manager
Cannara Biotech Inc
XTSX:LOVE
Watchlist
Price: 1.75 CAD 6.06% Market Closed
Market Cap: 160m CAD

Wall Street
Price Targets

LOVE Price Targets Summary
Cannara Biotech Inc

Wall Street analysts forecast LOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LOVE is 3.06 CAD with a low forecast of 3.03 CAD and a high forecast of 3.15 CAD.

Lowest
Price Target
3.03 CAD
73% Upside
Average
Price Target
3.06 CAD
75% Upside
Highest
Price Target
3.15 CAD
80% Upside
Cannara Biotech Inc Competitors:
Price Targets
4887
Sawai Group Holdings Co Ltd
32% Upside
300765
CSPC Innovation Pharmaceutical Co Ltd
83% Upside
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
60% Upside
EAH
ECO Animal Health Group PLC
130% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
23% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
32% Downside

Revenue
Forecast

Revenue Estimate
Cannara Biotech Inc

For the last 5 years the compound annual growth rate for Cannara Biotech Inc's revenue is 108%. The projected CAGR for the next 3 years is 19%.

108%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Cannara Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Cannara Biotech Inc

The compound annual growth rate of Cannara Biotech Inc's net income for the next 3 years is 42%.

N/A
Past Growth
42%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LOVE's stock price target?
Price Target
3.06 CAD

According to Wall Street analysts, the average 1-year price target for LOVE is 3.06 CAD with a low forecast of 3.03 CAD and a high forecast of 3.15 CAD.

What is Cannara Biotech Inc's Revenue forecast?
Projected CAGR
19%

For the last 5 years the compound annual growth rate for Cannara Biotech Inc's revenue is 108%. The projected CAGR for the next 3 years is 19%.

What is Cannara Biotech Inc's Net Income forecast?
Projected CAGR
42%

The compound annual growth rate of Cannara Biotech Inc's net income for the next 3 years is 42%.

Back to Top